HIV1 protease inhibitors selectively induce inflammatory chemokine expression in primary human osteoblasts

Antiviral Research

Volumn 74, Issue 1, 2007, Pages 72-76

  Malizia, Andrea P ^a   Vioreanu, Mihai H ^b   Doran, Peter P ^a   Powderly, William G ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b Dublin Molecular Medicine Centre   (Ireland)

Author keywords

HAART; IL 8; Inflammation; MCP 1; Nelfinavir; Osteoblasts; Ritonavir

Indexed keywords

CHEMOKINE; INDINAVIR; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ARTICLE; BONE DENSITY; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG EXPOSURE; DRUG SELECTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC CORRELATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; LINEAR REGRESSION ANALYSIS; MICROARRAY ANALYSIS; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL SIGNIFICANCE; VIRUS INFECTION;

CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIV PROTEASE INHIBITORS; HUMANS; INTERLEUKIN-8; NELFINAVIR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; RITONAVIR;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33847640563     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.12.003     Document Type: Article

References (21)

1. Baggiolini M., Dewald B., and Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55 (1994) 97-179
2. Ben-Baruch A., Michiel D.F., and Oppenheim J.J. Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem. 270 (1995) 11703-11706
3. Bolstad B.M., Irizarry R.A., Astrand M., and Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2003) 185-193
4. Carr A., Miller J., Eisman J.A., and Cooper D.A. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS 15 (2001) 703-709
5. Douglas A.H., Glynn Jr. D., Brad T.S., Clifford L.H., and Richard A.L. Identifying biological themes within lists of genes with EASE. Genome Biol. 4 (2003) P4
6. Duval X., Peytavin G., Albert I., Benoliel S., Ecobichon J.L., Brun-Vézinet F., Mentre F., Leport C., and Vilde J.L. Determination of indinavir and nelfinavir through plasma concentration efficacy thresholds according to virological response in HIV-infected patients. HIV Med. 5 (2004) 307-313
7. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 14863-14868
8. Graves D.T., Jiang Y., and Valente A.J. Regulated expression of MCP-1 by osteoblastic cells in vitro and in vivo. Histol. Histopathol. 14 (1999) 1347-1354
9. Jain R.G., and Lenhard J.M. Select HIV protease inhibitors alter bone and fat metabolism ex vivo. J. Biol. Chem. 277 (2002) 19247-19250
10. Kieran N.E., Doran P.P., Connolly S.B., Greenan M.C., Higgins D.F., Leonard M., Godson C., Taylor C.T., Henger A., Kretzler M., Burne M.J., Rabb H., and Brady H.R. Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int. 64 (2003) 480-492
11. Lawal A., Engelson E., Wang J., Heymsfield S.B., and Kotler D.P. Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapy. AIDS 15 (2001) 278-280
12. Liu Y.Z., Dvornyk V., Lu Y., Shen H., Lappe M.J., Recker R.R., and Deng H.W. A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J. Biol. Chem. 280 (2005) 29011-29016
13. Malizia A.P., Cotter E., Chew N., Powderly W.G., and Doran P.P. HIV-1 protease inhibitors selectively induce gene expression alterations associated with reduced calcium deposition in primary human osteoblasts. AIDS Res. Hum. Retroviruses 23 (2007) 135-141
14. McDermott A.Y., Shevitz A., Knox T., Roubenoff R., Kehayias J., and Gorbach S. Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women. Am. J. Clin. Nutr. 74 (2001) 679-686
15. Rothe L., Collin-Osdoby P., Chen Y., Sunyer T., Chaudhary L., Tsay A., Goldring S., Avioli L., and Osdoby P. Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. Endocrinology 139 (1998) 4353-4363
16. Safrin S., and Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. AIDS 13 (1999) 2493-2505
17. Sozzani S., Locati M., Allavena P., Van Damme J., and Mantovani A. Chemokines: a superfamily of chemotactic cytokines. Int. J. Clin. Lab. Res. 26 (1996) 69-82
18. Tebas P., Powderly W.G., Claxton S., Marin D., Tantisiriwat W., Teitelbaum S.L., and Yarasheski K.E. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14 (2000) F63-F67
19. Walsh C.A., Birch M.A., Fraser W.D., Ginty A.F., and Gallagher J.A. Cytokine expression by cultured osteoblasts from patients with osteoporotic fractures. Int. J. Exp. Pathol. 81 (2000) 159-163
20. Yoshimura T., Matsushima K., Tanaka S., Robinson E.A., Appella E., Oppenheim J.J., and Leonard E.J. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 9233-9237
21. Zwahlen R., Walz A., and Rot A. In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int. Rev. Exp. Pathol. 34 (1993) 27-42